Company Continues to Build International
Presence Leveraging Award-Winning, High-Quality Product
MONCTON, NB, May 17, 2018 /CNW/ - Organigram Holdings Inc.
(TSX VENTURE:OGI) (OTCQB:OGRMF) (the "Company" or
"Organigram"), a leading licensed producer of medical
marijuana based in Moncton, New
Brunswick today announces that it has received a "Permit to
Export Cannabis" from Health Canada that will allow the Company to
begin its first international shipments.
Organigram will now be able to ship dried cannabis products to
Cannatrek Medical PTY Ltd ("Cannatrek"), a licenced
Australian medical cannabis enterprise with operations in
Melbourne, Victoria through its broker Cannada Management
Group Global Inc. ("CMG"), a leading global cannabis and
hemp brokerage firm for import/export, procurement and logistics of
cannabis and hemp related products.
"Today we are proud to announce our ability to commence
international sales through the receipt of a Permit to Export
Cannabis from Health Canada," says Greg
Engel, CEO, Organigram. "This is only the
beginning. Last week we announced our intentions to invest in
and sell to a German distributor. Today we announce our ability to
sell into Australia. We continue
to strive towards becoming a global leader in the medical cannabis
trade."
Cannatrek CEO, Tommy Huppert,
commented, "We are very excited to have established a relationship
with Organigram. The import of medical cannabis products from a
leading Canadian licensed producer strongly positions Cannatrek to
capitalise on the rapidly evolving medical cannabis industry in
Australia and increase patient
access."
ABOUT CANNADA MANAGEMENT GROUP GLOBAL INC.
"CMG" is a leading global cannabis and hemp brokerage firm
dealing in product procurement, importing and exporting, logistics,
warehousing, distribution, sales and e-commerce. CMG is currently
working with global partners to establish a gold standard for
global distribution of medical grade cannabis and hemp products in
legalized markets. CMG has signed international broker agreements
for product, as well as successfully received government permits to
import product into Canada and
export product internationally for their clients.
For more information see www.cannadamanagement.com
ABOUT ORGANIGRAM HOLDINGS INC.
Organigram Holdings Inc. is a TSX Venture Exchange listed
company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of medical marijuana in Canada. Organigram is focused on producing the
highest quality, condition specific medical marijuana for patients
in Canada. Organigram's facility
is located in Moncton, New
Brunswick and the Company is regulated by the Access to
Cannabis for Medical Purposes Regulations ("ACMPR").
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
This news release contains forward-looking information which
involves known and unknown risks, uncertainties and other factors
that may cause actual events to differ materially from current
expectations. Important factors - including the availability of
funds, consummation of definitive documentation, federal and
extra-jurisdictional regulations and applicable laws, the results
of financing efforts, crop yields - that could cause actual results
to differ materially from the Company's expectations are disclosed
in the Company's documents filed from time to time on SEDAR (see
www.sedar.com). Readers are cautioned not to place undue reliance
on these forward-looking statements, which speak only as of the
date of this press release. The Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise.
SOURCE OrganiGram